Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis

Laboratory Investigation

Volumn 78, Issue 11, 1998, Pages 1385-1394

  Goede, Valentin ^a   Schmidt, Tobias ^a   Kimmina, Sarah ^a   Kozian, Detlef ^a   Augustin, Hellmut G ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BLOOD VESSEL; CELL MATURATION; CELL SURVIVAL; COMPETITIVE INHIBITION; CORPUS LUTEUM; EXTRACELLULAR MATRIX; GENE TARGETING; LUTEOLYSIS; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NERVE SPROUTING; NONHUMAN; OVARY CELL; OVARY CYCLE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANGIOPOIETIN-1; ANGIOPOIETIN-2; ANIMALS; BLOOD VESSELS; CATTLE; CORPUS LUTEUM; ENDOTHELIAL GROWTH FACTORS; ESTRUS; FEMALE; LYMPHOKINES; MEMBRANE GLYCOPROTEINS; NEOVASCULARIZATION, PHYSIOLOGIC; OVARY; PERICYTES; PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0031729982     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Alon T, Memo I, Itin A, Pe'er J, Stone J, and Keshet E (1995). Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1:1024-1028.
2. Augustin HG (1998a). Antiangiogenic tumour therapy: Will it work? Trends Pharmacol Sci 19:216-222.
3. Augustin HG. (in press, 1998b) Development of the vascular system in the corpus luteum. In: Risau W, editor: Morphogenesis of endothelium. Reading, UK: Harwood Academic Publishers.
4. Augustin HG, Braun K, Telemenakis I, Modlich U, and Kuhn W (1995). Ovarian angiogenesis: Phenotypic characterization of endothelial cells in a physiological model of blood vessel growth and regression. Am J Pathol 147:339-351.
5. Beck L Jr and D'Amore PA (1997). Vascular development: Cellular and molecular regulation. FASEB J 11:365-373.
6. Benjamin L, Memo I, and Keshet E (1998). A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 125:1591-1598.
7. Benjamin LE and Keshet E (1997). Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc Natl Acad Sci USA 94:8761-8766.
8. Bussolino F, Mantovani A, and Persico G (1997). Molecular mechanisms of blood vessel formation. Trends Biochem Sci 22:251-256.
9. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, and Nagy A (1996). Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380:435-439.
10. Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, Ryan TE, Bruno J, Radziejewski C, Maisonpierre PC, and Yancopoulos GD (1996). Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87:1161-1169.
11. Dvorak HF, Brown LF, Detmar M, and Dvorak AM (1995). Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146:1029-1039.
12. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ, and Moore MW (1996). Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380:439-442.
13. Gospodarowicz D, Cheng J, Lui GM, Baird A, Esch F, and Böhlen P (1985). Corpus luteum angiogenic factor is related to fibroblast growth factor. Endocrinology 117:2383-2391.
14. Hanahan D (1997). Signaling vascular morphogenesis and maintenance. Science 277:48-50.
15. Hanahan D and Folkman J (1996). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353-364.
16. Hirschi KK and D'Amore PA (1996). Pericytes in the microvasculature. Cardiovasc Res 32:687-698.
17. Hirschi KK, Rohovsky SA, and D'Amore PA (1998). PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J Cell Biol 141:805-814.
18. Jakob W, Jentzsch KD, Mauersberger B, and Oehme P (1977). Demonstration of angiogenesis-activity in the corpus luteum of cattle. Exp Pathol 13:231-236.
19. Kamat BR, Brown LF, Manseau EJ, Senger DR, and Dvorak HF (1995). Expression of vascular permeability factor/ vascular endothelial growth factor by human granulosa and theca lutein cells: Role in corpus luteum development. Am J Pathol 146:157-165.
20. Koblizek TI, Weiss C, Yancopoulos GD, Deutsch U, and Risau W (1998). Angiopoietin-1 induces sprouting angiogenesis in vitro. Curr Biol 8:529-532.
21. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, and Ferrara N (1989). Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-1309.
22. Lindahl P, Johansson BR, Leveen P, and Betsholtz C (1997). Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277:242-245.
23. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S. Sato TN, and Yancopoulos GD (1997). Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55-60.
24. Mandriota SJ, Menoud PA, and Pepper MS (1996). Transforming growth factor beta 1 down-regulates vascular endothelial growth factor receptor 2/flk-1 expression in vascular endothelial cells. J Biol Chem 271:11500-11505.
25. Modlich U, Kaup FJ, and Augustin HG (1996). Cyclic angiogenesis and blood vessel regression in the ovary: Blood vessel regression during luteolysis involves endothelial cell detachment and vessel occlusion. Lab Invest 74:771-780.
26. Nehls V and Drenckhahn D (1991). Heterogeneity of microvascular pericytes for smooth muscle type alpha-actin. J Cell Biol 113:147-154.
27. Nicosia RF and Ottinetti A (1990). Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro. Lab Invest 63:115-122.
28. Pepper MS (1997). Manipulating angiogenesis: From basic science to the bedside. Arterioscler Thromb Vase Biol 17: 605-619.
29. Plate KH, Breier G, Weich HA, and Risau W (1992). Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359:845-848.
30. Phillips HS, Hains J, Leung DW, and Ferrara N (1990). Vascular endothelial growth factor is expressed in rat corpus luteum. Endocrinology 127:965-967.
31. Ravindranath N, Little-Ihrig L, Phillips HS, Ferrara N, and Zeleznik AJ (1992). Vascular endothelial growth factor messenger ribonucleic acid expression in the primate ovary. Endocrinology 131:254-260.
32. Reynolds LP, Killilea SD, and Redmer DA (1992). Angiogenesis in the female reproductive system. FASEB J 6:886-892.
33. Risau W (1997). Mechanisms of angiogenesis. Nature 386: 671-674.
34. Shweiki D, Itin A, Neufeld G, Gitay-Goren H, and Keshet E (1993). Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J Clin Invest 91:2235-2243.
35. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, and Yancopoulos GD (1996). Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87:1171-1180.
36. Tsukada K, Matsushima T, and Yamanaka N (1996). Neovascularization of the corpus luteum of rats during the estrus cycle. Pathol Int 46:408-416.
37. Zheng J, Fricke PM, Reynolds LP, and Redmer DA (1994). Evaluation of growth, cell proliferation, and cell death in bovine corpora lutea throughout the estrous cycle. Biol Reprod 51:623-632.